Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.21.2
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Stockholders’ Equity - Schedule of Share-Based Compensation for Director Fees

The following is information regarding the number of shares issued to directors as payment for director fees in lieu of cash for the three and six months ended June 30, 2021 and 2020:

 

Three Months Ended June 30,
2021     2020
1,820     9,832

 

Six Months Ended June 30,
2021     2020
3,829     19,563
Stockholders’ Equity - Schedule of Stock Option Activity

Stock option activity under all of the Company’s Plans during the six months ended June 30, 2021 is summarized below:

    Shares     Weighted-average Exercise price per share    

Intrinsic
Value
(1)

(in thousands)

 
Outstanding at January 1, 2021     1,806,092     $ 7.12     $ 20,760  
Granted     40,030       20.61          
Exercised     447,900       2.59          
Expired / terminated     18,500       20.46          
Outstanding at June 30, 2021     1,379,722     $ 8.19     $ 14,916  

 

(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.
Stockholders’ Equity - Schedule of Common Stock Warrant Activity

Warrants have generally been issued in connection with financing transactions and for terms of up to five years. Common stock warrant activity for the six months ended June 30, 2021 was as follows:

    Shares     Weighted-average Exercise price per share    

Intrinsic
Value
(1)

(in thousands)

 
Outstanding at January 1, 2021     3,082,987     $ 3.82     $ 37,379  
Exercised     (1,593,971 )     3.07          
Outstanding at June 30, 2021     1,489,016     $ 4.62     $ 21,653  

 

(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.